دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Equitable cancer care at any age
doi : 10.1016/S1470-2045(23)00115-8
Volume 24, Issue 4, April 2023, Page 307
Use of artificial intelligence to enhance detection of nodal metastases
Reza Forghani
doi : 10.1016/S1470-2045(23)00101-8
Volume 24, Issue 4, April 2023, Pages 308-309
Adding PD-1 inhibition to chemoradiotherapy for oesophageal cancer
*Hanneke W M van Laarhoven, Peter S N van Rossum
doi : 10.1016/S1470-2045(23)00103-1
Volume 24, Issue 4, April 2023, Pages 309-310
Endoscopic surveillance: time for a paradigm shift in hereditary diffuse-type gastric cancer management?
Rachel Sophia van der Post, Tanya Maria Bisseling, Jolanda Marianne van Dieren
doi : 10.1016/S1470-2045(23)00094-3
Volume 24, Issue 4, April 2023, Pages 311-312
Radiotherapy facilities after the Türkiye–Syria earthquakes: lessons from the tragedy
Yavuz Anacak, Neslihan Kurtul, Didem Nasuhbeyoğlu, Ezgi Oymak, Hüseyin Cem Önal
doi : 10.1016/S1470-2045(23)00099-2
Volume 24, Issue 4, April 2023, Pages 312-314
Expression of concern Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study
doi : 10.1016/S1470-2045(23)00111-0
Volume 24, Issue 4, April 2023, Page e145
Correction to Lancet Oncol 2021; 22: 74–84
doi : 10.1016/S1470-2045(23)00116-X
Volume 24, Issue 4, April 2023, Page e146
Correction to Lancet Oncol 2023; 24: 228–38
doi : 10.1016/S1470-2045(23)00117-1
Volume 24, Issue 4, April 2023, Page e146
High concentrations of aflatoxin in Ugandan grains sparks public health concern
Elizabeth Gourd
doi : 10.1016/S1470-2045(23)00096-7
Volume 24, Issue 4, April 2023, Page 315
US Air Force to study nuclear missile base lymphomas
Bryant Furlow
doi : 10.1016/S1470-2045(23)00100-6
Volume 24, Issue 4, April 2023, Page 316
US Government sues to halt carcinogenic air pollution
Bryant Furlow
doi : 10.1016/S1470-2045(23)00105-5
Volume 24, Issue 4, April 2023, Page 317
The UK's re-entry into the Horizon Europe programme
Sharmila Devi
doi : 10.1016/S1470-2045(23)00106-7
Volume 24, Issue 4, April 2023, Page 318
India rolls out HPV vaccination
Talha Khan Burki
doi : 10.1016/S1470-2045(23)00118-3
Volume 24, Issue 4, April 2023, Page e147
Cyber-attacks on health-care systems
Sharmila Devi
doi : 10.1016/S1470-2045(23)00119-5
Volume 24, Issue 4, April 2023, Page e148
Training workshop to promote tobacco control in African countries
Manjulika Das
doi : 10.1016/S1470-2045(23)00120-1
Volume 24, Issue 4, April 2023, Page e149
Promoting cancer prevention through World Cancer Day in Nigeria
Runcie C W Chidebe, L Leigh Leibel, Tochukwu C Orjiakor, Ashish Shrestha, Agha A Agha, Duygu Altinok Dindar, Batuhan Kisakol, Sampson C Ipiankama, Ifeoma J Okoye, Malcolm Mason, Aviane Auguste, Darlingtina K Esiaka
doi : 10.1016/S1470-2045(22)00692-1
Volume 24, Issue 4, April 2023, Pages 319-322
Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial
Christopher J Sweeney, Andrew J Martin, Martin R Stockler, Stephen Begbie, Leanna Cheung, Kim N Chi, Simon Chowdhury, Mark Frydenberg, Lisa G Horvath, Anthony M Joshua, Nicola J Lawrence, Gavin Marx, John McCaffrey, Ray McDermott, Margaret McJannett, Scott A North, Francis Parnis, Wendy Parulekar, David W Pook, Martin Neil Reaume, Shahneen K Sandhu, Alvin Tan, Thean Hsiang Tan, Alastair Thomson, Francisco Vera-Badillo, Scott G Williams, Diana Winter, Sonia Yip, Alison Y Zhang, Robert R Zielinski, Ian D Davis, for the ENZAMET trial investigators* and Australian and New Zealand Urogenital and Prostate Cancer Trials Group
doi : 10.1016/S1470-2045(23)00063-3
Volume 24, Issue 4, April 2023, Pages 323-334
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry
Alessio Cortellini, Josep Tabernero, Uma Mukherjee, Ramon Salazar, Anna Sureda, Clara Maluquer, Daniela Ferrante, Mark Bower, Rachel Sharkey, Oriol Mirallas, Andrea Plaja, Marc Cucurull, Ricard Mesia, Alessia Dalla Pria, Thomas Newsom-Davis, Mieke Van Hemelrijck, Ailsa Sita-Lumsden, Eleanor Apthorp, Bruno Vincenzi, Giuseppina Rita Di Fazio, Giuseppe Tonini, Francesco Pantano, Alexia Bertuzzi, Sabrina Rossi, Joan Brunet, Matteo Lambertini, Paolo Pedrazzoli, Federica Biello, Francesca D’Avanzo, Alvin J X Lee, Marianne Shawe-Taylor, Lucy Rogers, Cian Murphy, Lee Cooper, Ramis Andaleeb, Saira Khalique, Samira Bawany, Sarah Ahmed, M Carmen Carmona-GarcÃa, Roser Fort-Culillas, Raquel Liñan, Federica Zoratto, Gianpiero Rizzo, Marta Perachino, Kris Doonga, Gianluca Gaidano, Riccardo Bruna, Andrea Patriarca, Clara Martinez-Vila, Ignacio Pérez Criado, Raffaele Giusti, Francesca Mazzoni, Lorenzo Antonuzzo, Armando Santoro, Alessandro Parisi, Paola Queirolo, Avinash Aujayeb, Lorenza Rimassa, Nikolaos Diamantis, Rossella Bertulli, Claudia A M Fulgenzi, Antonio D’Alessio, Isabel Ruiz-Camps, Nadia Saoudi-Gonzalez, David Garcia Illescas, Irene Medina, Laura Fox, Alessandra Gennari, Juan Aguilar-Company, David J Pinato, on behalf of the OnCovid study group
doi : 10.1016/S1470-2045(23)00056-6
Volume 24, Issue 4, April 2023, Pages 335-346
Tailored immunotherapy approach with nivolumab with or without ipilimumab in patients with advanced transitional cell carcinoma after platinum-based chemotherapy (TITAN-TCC): a multicentre, single-arm, phase 2 trial
Marc-Oliver Grimm, Christine Barbara Grün, Günter Niegisch, Martin Pichler, Florian Roghmann, Bernd Schmitz-Dräger, Gustavo Baretton, Marc Schmitz, Christian Bolenz, Susan Foller, Katharina Leucht, Ulrike Schumacher, Martin Schostak, Johannes Meran, Wolfgang Loidl, Friedemann Zengerling
doi : 10.1016/S1470-2045(23)00053-0
Volume 24, Issue 4, April 2023, Pages 347-359
Artificial intelligence-based model for lymph node metastases detection on whole slide images in bladder cancer: a retrospective, multicentre, diagnostic study
Shaoxu Wu*, Guibin Hong*, Abai Xu*, Hong Zeng*, Xulin Chen*, Yun Wang, Yun Luo, Peng Wu, Cundong Liu, Ning Jiang, Qiang Dang, Cheng Yang, Bohao Liu, Runnan Shen, Zeshi Chen, Chengxiao Liao, Zhen Lin, Jin Wang, Tianxin Lin
doi : 10.1016/S1470-2045(23)00061-X
Volume 24, Issue 4, April 2023, Pages 360-370
Toripalimab combined with definitive chemoradiotherapy in locally advanced oesophageal squamous cell carcinoma (EC-CRT-001): a single-arm, phase 2 trial
Yujia Zhu*, Jing Wen*, Qiaoqiao Li*, Baoqing Chen*, Lei Zhao*, Shiliang Liu, Yadi Yang, Sifen Wang, Yingxin Lv, Jibin Li, Li Zhang, Yonghong Hu†, Mengzhong Liu†, Mian Xiâ€
doi : 10.1016/S1470-2045(23)00060-8
Volume 24, Issue 4, April 2023, Pages 371-382
Cancer surveillance as an alternative to prophylactic total gastrectomy in hereditary diffuse gastric cancer: a prospective cohort study
Bilal Asif*, Amber Leila Sarvestani*, Lauren A Gamble, Sarah G Samaranayake, Amber L Famiglietti, Grace-Ann Fasaye, Martha Quezado, Markku Miettinen, Louis Korman, Christopher Koh, Theo Heller, Jeremy L Davis
doi : 10.1016/S1470-2045(23)00057-8
Volume 24, Issue 4, April 2023, Pages 383-391
Health-related quality of life with pembrolizumab or placebo plus chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer (KEYNOTE-826): a randomised, double-blind, placebo-controlled, phase 3 trial
Bradley J Monk, Krishnansu S Tewari, Coraline Dubot, M Valeria Caceres, Kosei Hasegawa, Ronnie Shapira-Frommer, Pamela Salman, Eduardo Yañez, Mahmut Gümüş, Mivael Olivera Hurtado de Mendoza, Vanessa Samouëlian, Vincent Castonguay, Alexander Arkhipov, Cumhur Tekin, Kan Li, Allison Martin Nguyen, Matthew J Monberg, Nicoletta Colombo, Domenica Lorusso
doi : 10.1016/S1470-2045(23)00052-9
Volume 24, Issue 4, April 2023, Pages 392-402
Prevalence of human papillomavirus DNA and p16INK4a positivity in vulvar cancer and vulvar intraepithelial neoplasia: a systematic review and meta-analysis
Zhuang Li*, Penglin Liu*, Ziying Wang, Zhaoyang Zhang, Zhongshao Chen, Ran Chu, Guiju Li, Qiuyue Han, Yong Zhao, Li Li, Jinwei Miao†, Beihua Kong†, Kun Songâ€
doi : 10.1016/S1470-2045(23)00066-9
Volume 24, Issue 4, April 2023, Pages 403-414
From the European Medicines Agency to Project Orbis: new activities and challenges to facilitate UK oncology drug approval following Brexit
Mark P Lythgoe, Jonathan Krell, Mark Bower, Ravindhi Murphy, John Marriott, Sarah P Blagden, Ajay Aggarwal, Richard Sullivan
doi : 10.1016/S1470-2045(22)00701-X
Volume 24, Issue 4, April 2023, Pages e150-e160
Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference
Rifaquat Rahman*, Mei-Yin C Polley*, Laura Alder, Priscilla K Brastianos, Carey K Anders, Hussein A Tawbi, Minesh Mehta, Patrick Y Wen, Susan Geyer, John de Groot, Gelareh Zadeh, Steven Piantadosi, Evanthia Galanis*, Mustafa Khasraw
doi : 10.1016/S1470-2045(23)00005-0
Volume 24, Issue 4, April 2023, Pages e161-e171
Multinational Association of Supportive Care in Cancer (MASCC) clinical practice guidelines for the prevention and management of acute radiation dermatitis: international Delphi consensus-based recommendations
Tara Behroozian, Pierluigi Bonomo, Partha Patel, Lauren Kanee, Samuel Finkelstein, Corina van den Hurk, Edward Chow*, Julie Ryan Wolf* on behalf of the Multinational Association of Supportive Care in Cancer (MASCC) Oncodermatology Study Group Radiation Dermatitis Guidelines Working Groupâ€
doi : 10.1016/S1470-2045(23)00067-0
Volume 24, Issue 4, April 2023, Pages e172-e185
Rare primary prostate cancer presenting with testicular and hip pain
Matthew Au, Ricardo Almeida-Magana, Tarek Al-Hammouri, Aiman Haider, Danilo Miskovic, Greg Shaw
doi : 10.1016/S1470-2045(23)00002-5
Volume 24, Issue 4, April 2023, Page e186
